Skip to main content

Advertisement

Log in

Epstein-Barr virus-associated pneumonia and bronchiolitis obliterans syndrome in a lung transplant recipient

  • Original Investigation
  • Published:
Medical Microbiology and Immunology Aims and scope Submit manuscript

Abstract

We report the case of a 25-year-old lung and liver transplant recipient who developed respiratory failure. High levels of Epstein-Barr virus (EBV) genome copies were detectable in respiratory tract specimens, while the search for various other viral, bacterial or fungal pathogens remained empty. Post-transplant lymphoproliferative disease was excluded. Due to the rapid progression of respiratory insufficiency, a re-transplantation of the lung was performed. EBV-encoded small RNAs could be demonstrated by in situ hybridization within pneumocytes and lymphocytes of the explanted lung tissue. The clinical situation improved soon after re-transplantation, and the EBV load detected in the lower respiratory tract decreased significantly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Kieff E, Rickinson AB (2007) Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology. Lippincott-Williams & Wilkins Publishers, Philadelphia, pp 2603–2654

    Google Scholar 

  2. Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT (1984) Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 81:4510–4514

    Google Scholar 

  3. Macsween KF, Crawford DH (2003) Epstein-Barr virus-recent advances. Lancet Infect Dis 3:131–140

    Google Scholar 

  4. Golden HD, Chang RS, Prescott W, Simpson E, Cooper TY (1973) Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals. J Infect Dis 127:471–473

    Google Scholar 

  5. Straus SE, Cohen JI, Tosato G, Meier J (1993) NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med 118:45–58

    Google Scholar 

  6. Hsu JL, Glaser SL (2000) Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol 34:27–53

    Google Scholar 

  7. Young LS, Rickinson AB (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4:757–768

    Article  CAS  PubMed  Google Scholar 

  8. Ternesten-Bratel A, Kjellstrom C, Ricksten A (1998) Specific expression of Epstein-Barr virus in cutaneous squamous cell carcinomas from heart transplant recipients. Transplantation 66:1524–1529

    Article  CAS  PubMed  Google Scholar 

  9. Hyckel P, Schleier P, Meerbach A, Berndt A, Kosmehl H, Wutzler P (2003) The therapy of virus-associated epithelial tumors of the face and the lips in organ transplant recipients. Med Microbiol Immunol 192:171–176

    Article  PubMed  Google Scholar 

  10. Fan H, Gulley ML (2001) Epstein-Barr viral load measurement as a marker of EBV-related disease. Mol Diagn 6:279–289

    CAS  PubMed  Google Scholar 

  11. Baldanti F, Grossi P, Furione M, Simoncini L, Sarasini A, Comoli P, Maccario R, Fiocchi R, Gerna G (2000) High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J Clin Microbiol 38:613–619

    CAS  PubMed  Google Scholar 

  12. Rowe DT, Qu L, Reyes J, Jabbour N, Yunis E, Putnam P, Todo S, Green M (1997) Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol 35:1612–1615

    CAS  PubMed  Google Scholar 

  13. Lucas KG, Burton RL, Zimmerman SE, Wang J, Cornetta KG, Robertson KA, Lee CH, Emanuel DJ (1998) Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood 91:3654–3661

    CAS  PubMed  Google Scholar 

  14. Gärtner BC, Schafer H, Marggraff K, Eisele G, Schafer M, Dilloo D, Roemer K, Laws HJ, Sester M, Sester U, Einsele H, Mueller-Lantzsch N (2002) Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease. J Clin Microbiol 40:351–358

    Article  PubMed  Google Scholar 

  15. Kimura H, Ito Y, Suzuki R, Nishiyama Y (2008) Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev Med Virol 18:305–319

    Article  CAS  PubMed  Google Scholar 

  16. Krumbholz A, Meerbach A, Zell R, Gruhn B, Henke A, Birch-Hirschfeld E, Wutzler P (2006) Comparison of a LightCycler-based real-time PCR for quantitation of Epstein-Barr viral load in different clinical specimens with semiquantitative PCR. J Med Virol 78:598–607

    Article  CAS  PubMed  Google Scholar 

  17. Costa C, Elia M, Astegiano S, Sidoti F, Terlizzi ME, Solidoro P, Botto S, Libertucci D, Bergallo M, Cavallo R (2008) Quantitative detection of Epstein-Barr virus in bronchoalveolar lavage from transplant and nontransplant patients. Transplantation 86:1389–1394

    Article  PubMed  Google Scholar 

  18. Stocher M, Leb V, Bozic M, Kessler HH, Halwachs-Baumann G, Landt O, Stekel H, Berg J (2003) Parallel detection of five human herpes virus DNAs by a set of real-time polymerase chain reactions in a single run. J Clin Virol 26:85–93

    Article  CAS  PubMed  Google Scholar 

  19. Lung ML, Lam WK, So SY, Lam WP, Chan KH, Ng MH (1985) Evidence that respiratory tract is major reservoir for Epstein-Barr virus. Lancet 1:889–892

    Article  CAS  PubMed  Google Scholar 

  20. Haller A, von Segesser L, Baumann PC, Krause M (1995) Severe respiratory insufficiency complicating Epstein-Barr virus infection: case report and review. Clin Infect Dis 21:206–209

    CAS  PubMed  Google Scholar 

  21. Gautschi O, Berger C, Gubler J, Laube I (2003) Acute respiratory failure and cerebral hemorrhage due to primary Epstein-Barr virus infection. Respiration 70:419–422

    Article  CAS  PubMed  Google Scholar 

  22. Sriskandan S, Labrecque LG, Schofield J (1996) Diffuse pneumonia associated with infectious mononucleosis: detection of Epstein-Barr virus in lung tissue by in situ hybridization. Clin Infect Dis 22:578–579

    CAS  PubMed  Google Scholar 

  23. Barbera JA, Hayashi S, Hegele RG, Hogg JC (1992) Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization. Am Rev Respir Dis 145:940–946

    CAS  PubMed  Google Scholar 

  24. Egan JJ, Stewart JP, Hasleton PS, Arrand JR, Carroll KB, Woodcock AA (1995) Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax 50:1234–1239

    Article  CAS  PubMed  Google Scholar 

  25. Remund KF, Best M, Egan JJ (2009) Infections relevant to lung transplantation. Proc Am Thorac Soc 6:94–100

    Article  PubMed  Google Scholar 

  26. Gottschalk S, Rooney CM, Heslop HE (2005) Post-transplant lymphoproliferative disorders. Annu Rev Med 56:29–44

    Article  CAS  PubMed  Google Scholar 

  27. Armitage JM, Kormos RL, Stuart RS, Fricker FJ, Griffith BP, Nalesnik M, Hardesty RL, Dummer JS (1991) Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 10:877–886; discussion 886–877

    Google Scholar 

  28. Aris RM, Maia DM, Neuringer IP, Gott K, Kiley S, Gertis K, Handy J (1996) Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naive lung transplant recipient. Am J Respir Crit Care Med 154:1712–1717

    CAS  PubMed  Google Scholar 

  29. Levine SM, Angel L, Anzueto A, Susanto I, Peters JI, Sako EY, Bryan CL (1999) A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipients. Chest 116:1273–1277

    Article  CAS  PubMed  Google Scholar 

  30. Walker RC, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, McGregor CG, Paya CV (1995) Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis 20:1346–1353

    CAS  PubMed  Google Scholar 

  31. Kranz B, Vester U, Becker J, Woltering T, Wingen AM, Paul A, Hoyer PF (2006) Unusual manifestation of posttransplant lymphoproliferative disorder in the esophagus. Transplant Proc 38:693–696

    Article  CAS  PubMed  Google Scholar 

  32. Michelson P, Watkins B, Webber SA, Wadowsky R, Michaels MG (2008) Screening for PTLD in lung and heart-lung transplant recipients by measuring EBV DNA load in bronchoalveolar lavage fluid using real time PCR. Pediatr Transplant 12:464–468

    Article  PubMed  Google Scholar 

  33. Christie JD, Edwards LB, Aurora P, Dobbels F, Kirk R, Rahmel AO, Taylor DO, Kucheryavaya AY, Hertz MI (2008) Registry of the international society for heart and lung transplantation: twenty-fifth official adult lung and heart/lung transplantation report-2008. J Heart Lung Transplant 27:957–969

    Article  PubMed  Google Scholar 

  34. Meyers BF, de la Morena M, Sweet SC, Trulock EP, Guthrie TJ, Mendeloff EN, Huddleston C, Cooper JD, Patterson GA (2005) Primary graft dysfunction and other selected complications of lung transplantation: a single-center experience of 983 patients. J Thorac Cardiovasc Surg 129:1421–1429

    Article  PubMed  Google Scholar 

  35. Hachem RR (2009) Lung allograft rejection: diagnosis and management. Curr Opin Organ Transplant 14:477–482

    Article  PubMed  Google Scholar 

  36. Grossman EJ, Shilling RA (2009) Bronchiolitis obliterans in lung transplantation: the good, the bad, and the future. Transl Res 153:153–165

    Article  PubMed  Google Scholar 

  37. Gulley ML (2001) Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol Diagn 3:1–10

    CAS  PubMed  Google Scholar 

  38. Weigel R, Fischer DK, Heston L, Miller G (1985) Constitutive expression of Epstein-Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein-Barr virus replication. J Virol 53:254–259

    CAS  PubMed  Google Scholar 

  39. Neurohr C, Huppmann P, Leuchte H, Schwaiblmair M, Bittmann I, Jaeger G, Hatz R, Frey L, Uberfuhr P, Reichart B, Behr J (2005) Human herpesvirus 6 in bronchoalveolar lavage fluid after lung transplantation: a risk factor for bronchiolitis obliterans syndrome? Am J Transplant 5:2982–2991

    Article  CAS  PubMed  Google Scholar 

  40. Engelmann I, Welte T, Fuhner T, Simon AR, Mattner F, Hoy L, Schulz TF, Gottlieb J (2009) Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation. J Clin Virol 45:47–53

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andi Krumbholz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krumbholz, A., Sandhaus, T., Göhlert, A. et al. Epstein-Barr virus-associated pneumonia and bronchiolitis obliterans syndrome in a lung transplant recipient. Med Microbiol Immunol 199, 317–322 (2010). https://doi.org/10.1007/s00430-010-0165-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00430-010-0165-y

Keywords

Navigation